DOI:
10.1055/s-00000045
Der Nuklearmediziner
LinksClose Window
References
Benešová M, Schäfer M, Bauder-Wüst U et al.
Preclinical evaluation of a tailor-made DOTA-conjugated PSMA inhibitor with optimized linker moiety for imaging and endoradiotherapy of prostate cancer.
J Nucl Med 2015 Apr 16
: - pii: jnumed.114.147413. [Epub ahead of print]
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.